Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-24 @ 9:43 PM
Study NCT ID:
NCT00230334
Status:
TERMINATED
Last Update Posted:
2021-05-10
First Post:
2005-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
Sponsor:
Steven E. Coutre
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB 79112 (old system)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |